Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-11
2005-10-11
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S456000, C514S576000, C514S733000
Reexamination Certificate
active
06953786
ABSTRACT:
Disclosed are methods for treating, preventing, or inhibiting cancer in a subject comprising administering at least one polyphenolic compound and at least one inhibitor of reactive oxygen species to the subject. The polyphenolic compound may be derived or isolated from plants. In some embodiments, the polyphenolic compound is a flavonoid. In other embodiments, the polyphenolic compound is a non-flavonoid. Other methods and kits are also disclosed as well as pharmaceutical compositions.
REFERENCES:
patent: 6410061 (2002-06-01), Morre et al.
patent: 6428818 (2002-08-01), Morre et al.
Cecil Textbook of Medicine, 21stedition, vol. 1, Goldman et al., eds., published 2000 by Saunders Co., (PA), pp. 1060-1074.
Weyant et al, Cancer Research, vol. 61, pp. 118-25, Jan. 2001.
Lee et al, Cell Death & Diff, vol. 7, pp. 925-32, 2000.
Vaquero et al, Pancreatology, vol. 2, pp. 217-361 (abstract), 2002.
Yamamoto et al, J. Clin. Invest., vol. 107, pp. 135-142, 2001.
Beers et al, Molecular Breeding of Woody Plants, pp. 43-52, 2001.
Ahmad, N., et al. (2000) “Green Tea Polyphenol Epigallocatechin-3-Gallate Differentially Modulates Nuclear Factor κB in Cancer Cells Versus Normal Cells”, Archives of Biochemistry and Biophysics, vol. 376, No. 2, pp. 338-346.
Babior, B.M (1999) “NADPH Oxidase: An Update” Blood, vol. 93, No. 5, pp. 1464-1476.
Balla, T. (2001) “Pharmacology of Phosphoinositides, Regulators of Multiple Cellular Functions” Current Pharmaceutical Design, vol. 7, pp. 475-507.
Bos, J. L. (1989) “rasOncogenes in Human Cancer: A Review”, Cancer Research, vol. 49, pp. 4682-4689.
Bravo, L. (1998) “Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance” Nutrition Reviews, vol. 56, No. 11, pp. 317-333.
Cohen, J. (1993) “Overview: Mechanisms of apoptosis”, Immunology Today, vol. 14, No. 3, pp. 126-130.
Crompton, M. (1999) “The mitochondrial permeability transition pore and its role in cell death”, Biochemical Society, vol. 341, pp. 233-249.
Davis, Jr., W. et al., (2000) “Cellular Thiols and Reactive Oxygen Species in Drug-Induced Apoptosis”, The Journal of Pharmacology and Experimental Therapeutics, vol. 296, No. 1, pp. 1-6.
DiMagno, E. et al., (1999) “AGA Technical Review on the Epidemiology, Diagnosis, and Treatment of Pancreatic Ductal Adenocarcinoma”, American Gastroenterological Association, vol. 117, No. 6, pp. 1464-1484.
Sussman, J. et al., (1995) “The death domain: a module shared by proteins with diverse cellular functions”, TIBS, pp. 342-344.
Flohé, L., et. al., (1997) “Redox Regulation of NF-Kappa B Activation”, Free Radical Biology & Medicine, vol. 22, No. 6, pp. 1115-1126.
Freeman, B. et al., (1982) “Free Radicals and Tissue Injury”, Laboratory Investigation, vol. 47, No. 5, pp. 412-426.
Goldman, R. et al, (1997) “Activation of Map Kinases, cPLA2, and Reactive Oxygen Species Formation By EGF and Calcium Mobilizing Agonists in a Human Keratinocyte Cell Line”, Eicosanoids and other Bioactive Lipids in Cancer inflammation and Radiation Injury 3, pp. 289-293.
Green, D. (1998) “Apoptotic Pathways: The Roads to Ruin” Cell, vol. 94, pp. 695-698.
Green, D. et al, (1998) “Mitochondria and Apoptosis”Science,vol. 281, pp. 1309-1312.
Gukovskaya, A. et al., (1996) “Mechanisms of Cell Death After Pancreatic Duct Obstruction in the Opossum and the Rat” American Gastroenterlogical Association, vol. 110, pp. 875-884.
Gukovskaya, A. et al., (1997) “Pancreatic Acinar Cells Produce, Release, and Respond to Tumor necrosis Factor-α” The Journal of Clinical Investigation, vol. 100, 1853-1862.
Gupta, S. (2000) “Growth Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Green Tea Constituent (-) Epigallocatechin-3-gallate in Androgen-Sensitive and Androgen-Insensitive Human Prostate Carcinoma Cells” Toxicology and Applied Pharmacology, vol. 164, pp. 82-90.
Hotz, H. et al., (2001) “An Improved Clinical Model of Orthotopic Pancreatic Cancer in Immunocompetent Lewis Rats” Pancreas, vol. 22, No. 2, pp. 113-121.
Hsieh, Tze-chen et al., (1999) “Differential Effects on Growth, Cell Cycle Arrest, and Induction of Apoptosis by Resveratrol in Human Prostate Cancer Cell Lines” Experimental Cell Research, vol. 249, pp. 109-115.
Hsu, H. et al., (1995) “The TNF Receptor I-Associated Protein TRADD Signals Cell Death and NF-κB Activation” Cell, vol. 81, pp. 495-504.
Huang, C. et al., (1999) “Resveratrol Suppresses Cell Transformation and Induces Apoptosis Through a p53-dependent Pathway” Carcinogenesis, vol. 20, No. 2, pp. 237-242.
Hsu, H. et al., (1996) “TRADD-TRAF2 and TRADD-FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways” Cell, vol. 84, pp. 299-308.
Islam, S. et al., (2000) “Involvement of Caspase-3 in Epigallocatechin-3-gallate-Mediated Apoptosis of Human Chondrosarcoma Cells” Biochem. And Biophys Research Comm., vol. 270, pp. 793-797.
Jang, M. et al., (1997) “Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes” Science, vol. 275, pp. 218-220.
Kandel, E. et al., (1999) “The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKB” Experimental Cell Research, vol. 253, pp. 210-229.
Kane, L. et al., (1999) “Induction of NF-κB by the Akt/PKB Kinase” Current Biology, vol. 9, No. 11, pp. 601-604.
Katada, T. et al., (1999) “Synergistic Activation of a Family of Phospphoinositide 3-kinase via G-protein Coupled and Tyrosine Kinase-related Receptors” Chemistry and Physics of Lipids, pp. 79-86.
Kong, Q. et al., (1998) “Antioxidant Inhibitors for Cancer Therapy” Medical Hypotheses, vol. 51, pp. 405-409.
Kroemer, G. et al., (2000) “Mitochondrial Control of Cell Death” Natural Medicine, vol. 6, No. 5, pp. 513-519.
LaCasse, E. et al., (1998) “The Inhibitors of Apoptosis (IAPs) and Their Emerging Role in Cancer” AE Mackenzie, pp. 3247-3259.
Leevers, S. (1999) “Signalling Through Phosphoinositide 3-kinases: The Lipids Take Centre Stage” Cell Biology, pp. 219-225.
Lepri, E., et al., (2000) “N-Acetylcysteine Increases Apoptosis Induced by H2O2and mo-antiFas Triggering in an 3DO Hybridoma Cell Line” Cell Biochem, vol. 18, pp. 201-208.
Li, H. et al., (2000) “Green Tea Polyphenols induce Apoptosis in Vitro in Peripheral Blood T Lymphocytes of Adult T-Cell Leukemia Patients” Jpn. J.Cancer Res., vol. 91, pp. 34-40.
Lin, K. et al., (1999) “Decreased Intracellular Superoxide Levels Activate Sindbis Virus-induced Apoptosis” Journal of Biological Chemistry, vol. 274, No. 19, pp. 13650-13655.
Madrid, L. et al., (2001) “Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38” Journal of Biological Chemistry, vol. 276, pp. 18934-18940.
McDade, T. et al., (1999) Salicylates Inhibit NF-κB Activation and Enhance TNF-a-induced Apoptosis in Human Pancreatic Cancer Cells, Journal of Surgical Research, vol. 83, pp. 56-61.
Madrid, L. et al., (2000) “Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB” Molecular and Cellular Bio., pp. 1626-1638.
Mourai, M. et al., (2002) “Food-derived Polyphenols Inhibit Pancreatic Cancer Growth Through Mitochondrial Cytochrome C Release and Apoptosis”, Int. J. Cancer, vol. 98, pp. 761-769.
Nakamura, H. et al., (1997) Redox Regulation of Cellular Activation Anu. Rev. Immunol., vol. 15, pp. 351-369.
Norell, S. et al., (1986) “Diet and Pancreatic Cancer: A Case-Control Study” American Journal of Epidemiology, vol., 124, No. 6, pp.
Gukovskaya Anna
Pandol Stephen J.
Henley III Raymond J.
Smith , Gambrell & Russell, LLP
Sundby Suzannah K.
The Regents of the University of California
The United States of America as represented by the Department of
LandOfFree
Compositions comprising plant-derived polyphenolic compounds... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions comprising plant-derived polyphenolic compounds..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions comprising plant-derived polyphenolic compounds... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437228